NEW YORK (360Dx) – University of Gothenburg researchers have validated neurofilament light protein as a concussion biomarker that clinicians could eventually use to decide when it's safe for sports participants to return to the field of play.
NEW YORK (360Dx) – University of Gothenburg researchers have validated neurofilament light protein as a concussion biomarker that clinicians could eventually use to decide when it's safe for sports participants to return to the field of play.
360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a 360Dx or GenomeWeb Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.